Diaceutics PLC Cash Flow-to-Debt Ratio
Diaceutics PLC cash flow-to-debt ratio. Diaceutics PLC (DXRX) has a Cash Flow-to-Debt Ratio of 0.07x as of December 2025, meaning its operating cash flow of GBX696.00K could theoretically repay 0% of its total liabilities (GBX9.53 Million) in one year. Check Diaceutics PLC (DXRX) total reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Cash Flow-to-Debt Ratio of Diaceutics PLC (2016–2025)
Cash flow-to-debt ratio of Diaceutics PLC from 2016 to 2025. Historical debt coverage capacity for Diaceutics PLC across 10 annual periods. Check Diaceutics PLC cash flow quality index to evaluate the quality of earnings relative to operating cash generation.
Diaceutics PLC Cash Flow-to-Debt Ratio by Year (2016–2025)
Diaceutics PLC cash flow-to-debt ratio by year from 2016 to 2025. Year-by-year debt coverage analysis for Diaceutics PLC. For the full cash flow conversion analysis, see DXRX cash generation efficiency.
| Year | CF-to-Debt Ratio | Operating CF (GBX) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | 0.16x | GBX1.50 Million | GBX9.53 Million | ▲ +111.3% |
| 2024 | 0.07x | GBX651.00K | GBX8.76 Million | ▼ -68.5% |
| 2023 | 0.24x | GBX1.31 Million | GBX5.56 Million | ▼ -73.4% |
| 2022 | 0.89x | GBX5.10 Million | GBX5.74 Million | ▲ +579.5% |
| 2021 | 0.13x | GBX570.00K | GBX4.36 Million | ▲ +69.4% |
| 2020 | 0.08x | GBX253.00K | GBX3.28 Million | ▲ +127.5% |
| 2019 | -0.28x | GBX-627.05K | GBX2.24 Million | ▼ -52.1% |
| 2018 | -0.18x | GBX-954.04K | GBX5.18 Million | ▼ -143.4% |
| 2017 | 0.42x | GBX1.53 Million | GBX3.61 Million | ▲ +52.9% |
| 2016 | 0.28x | GBX674.01K | GBX2.43 Million | — |